Skip to content

Early Screening and Optimized Management of Familial Hypercholesterolemia in High-Risk Populations: A Prospective Cohort Study at the First Affiliated Hospital of Xinjiang Medical University

Early Screening and Optimized Management of Familial Hypercholesterolemia in High-Risk Populations: A Prospective Cohort Study at the First Affiliated Hospital of Xinjiang Medical University

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085225
Enrollment
Unknown
Registered
2024-06-03
Start date
2024-06-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

familial hypercholesterolemia

Interventions

non-familial hypercholesterolemia patient group :None
familial hypercholesterolemia patient group :None

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The research subjects of this study were all from the population undergoing self hospital physical examination. In this population, the results of blood lipid testing were first screened to determine the hyperlipidemia patients among the healthy population undergoing physical examination; Among the screened patients with hyperlipidemia, individuals who meet the following inclusion and exclusion criteria will be included in the study cohort as FH group and non FH group, respectively; 2. FH group inclusion criteria: Those who meet two of the following three criteria: (1) Serum LDL-C = 4.90mmol/L in patients who have not received lipid-lowering drug treatment; (2) Having skin/tendon xanthoma or<45 years old but with fatty corneal arch; (3) FH or early-onset ASCVD among first-degree relatives, especially CAD patients; 3. Inclusion criteria for non FH group: Patients who are clearly diagnosed with hyperlipidemia but do not meet the FH diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Patients who may experience secondary elevation of LDL-C levels due to complications, such as hypothyroidism, nephrotic syndrome, and biliary obstruction. 2. Patients who are unable to provide LDL-C levels or have not undergone LDL-C testing. 3. People with mental or neurological dysfunction who are unable to express themselves.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular and cerebrovascular events;

Secondary

MeasureTime frame
all-cause mortality;myocardial infarct;heart failure;

Countries

China

Contacts

Public ContactDilare·Adi

The First Affiliated Hospital of Xinjiang Medical University

dil515@sina.com+86 131 7991 6117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026